Post by
Ellesse on Sep 13, 2016 1:34pm
Valeant will buy CXR for $18.00 CAD....
Is it possible that Valeant will buy CXR for $18.00 ?????
Comment by
Craigbad on Sep 13, 2016 1:40pm
If you do a little research, you'll find that Valeant passed on the assets that Concordia bought. They didn't pass Valeants smell test, as low as that bar is. Thankfully, Concordia was there so private equity had somewhere to dump them.
Comment by
LaticelnExile on Sep 13, 2016 2:12pm
This post has been removed in accordance with Community Policy
Comment by
greatplay on Sep 13, 2016 1:41pm
Personally I would prefer a merger with growing biotechnology, like BLUE, etc It will create a synergy, continuous cashflow (from legacy and some new - Concordia) + top research (biotechnology firm) It will remove from short attacks, because any approval by FDA (from bio side) can propel stocks high. In the same time will provide growth perspective, which is not big from Concordia.
Comment by
LaticelnExile on Sep 13, 2016 1:54pm
This post has been removed in accordance with Community Policy